Author | Craig L. Tendler, MD | OncLive

Author | Craig L. Tendler, MD

Articles

Dr. Tendler on Breakthrough Designation for Ibrutinib

June 26, 2013

Video

Craig L. Tendler, MD, Vice President, Late Development and Global Medical Affairs for Oncology, Janssen Oncology, discusses the importance of ibrutinib's Breakthrough Therapy Designation.

x